The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: A systematic review and meta-analysis.
 
Antonios Katsarolis
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I)
 
Maria Anastasiou
No Relationships to Disclose
 
Abraham Pouliakis
No Relationships to Disclose
 
Amanda Psyrri
Honoraria - Astrazeneca; Bayer; BMS; Genesis Pharmaceuticals; GlaxoSmithKline; Merck Serono; merus; MSD Oncology; Pfizer; Roche; seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; eTheRNA immunotherapies; GlaxoSmithKline; Merus NV; MSD Oncology; Pfizer; Seagen
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
 
Elena Fountzilas
Stock and Other Ownership Interests - Deciphera; Genprex
Honoraria - Amgen; AstraZeneca; AstraZeneca (I); Pfizer; Roche; Roche/Genentech
Consulting or Advisory Role - Amgen; Pfizer (I); Roche (I); Sanofi (I)
Travel, Accommodations, Expenses - AstraZeneca; Genesis Pharmaceuticals; Pfizer